RELISTOR tablets and injection are contraindicated in patients with known or suspected mechanical gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation.
INDICATIONS
RELISTOR® is an opioid antagonist. RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
IMPORTANT SAFETY INFORMATION
RELISTOR tablets and injection are contraindicated in patients with known or suspected mechanical gastrointestinal obstruction and patients at increased risk of recurrent obstruction, due to the potential for gastrointestinal perforation.
You are now entering a site that is for US healthcare professionals only. By selecting I Confirm below, you certify that you are a US healthcare professional and wish to proceed to this section of the site. Products or treatments described on this site are available in the United States but may not be available in all other countries.
I certify that I am a licensed US healthcare professional and wish to proceed to the healthcare professional section of this site.
Thank you for visiting the RELISTOR website; you are now leaving our site. The website you are about to visit is not affiliated with Salix Pharmaceuticals or its affiliated entities, and Salix is not responsible for the content, format, maintenance, or policies of the website you are about to visit. Salix Pharmaceuticals or its affiliated entities do not monitor non-affiliated websites for accuracy. This link does not imply endorsement or support of any programs, products, or services associated with the website.